Dechra Appoints New Chief Corporate Strategy & Business Development Officer

In this newly created role, Justine will partner with colleagues across the business to help shape Dechra's long-term strategic direction and identify opportunities to accelerate sustainable growth as the company strives to become the leading animal health company in specialty care. 

Justine brings more than 20 years of global experience in corporate strategy, business development, M&A, licensing, portfolio transformation, and investment banking across the animal health and life sciences industries.  

“Justine brings considerable knowledge of the business development landscape within animal health. Her expertise and passion will be a valuable addition to our Senior Executive Team as we continue our journey to better serve veterinarians and pet parents and in turn, strengthen the communities we call home,” said Jesper Nordengaard, CEO. 

Most recently, she served as Vice President of Business Development at Elanco Animal Health, where she played an important role in the company’s transformation, leading strategic transactions that strengthened both the portfolio and the balance sheet. Earlier in her career, she advised clients on strategic transactions and capital markets at Bank of America Merrill Lynch and Macquarie Group. 

“I am excited to join Dechra at such an important stage in its evolution. The company’s strong portfolio, deep expertise and commitment to innovation provide a compelling foundation for growth. We have a significant opportunity ahead of us and I look forward to working with colleagues across the business to help shape and deliver our strategy” said Justine Conway.